We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

73 hedge funds and large institutions have $47.1M invested in Marrone Bio Innovations, Inc. in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

1% more funds holding

Funds holding: 7273 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

24% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 25

48% less capital invested

Capital invested by funds: $91.4M → $47.1M (-$44.3M)

Holders
73
Holders Change
+1
Holders Change %
+1.39%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
19
Reduced
25
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
-$8K -5,077 Closed
KFAA
77
Klaas Financial Asset Advisors
Illinois
-$3K -1,650 Closed
PHK
78
Point72 Hong Kong
Hong Kong
-$360 -299 -39%
EI
79
Ellevest Inc
New York
+$252 +209 New

MBII Hedge Fund Activity: Q3 2021 in Review

73 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2021, worth a combined $47.1M — down 48% from $91.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MBII positions and 8 closed out — a net gain of 2 holders — while 19 added to existing stakes and 25 trimmed.

The largest buyer was Oak Family Advisors, opening a new position worth an estimated $751K. The largest seller was Macquarie Group, cutting an estimated $3.16M.

  • 73 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2021, up from 72 in Q2 2021.
  • Funds reported $47.1M of Marrone Bio Innovations, Inc. stock for Q3 2021, down 48% quarter-over-quarter.
  • 10 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2021 and 8 closed out, a net change of +2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q3 2021 was Oak Family Advisors, an estimated $751K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q3 2021 was Macquarie Group, an estimated $3.16M sold.

Based on aggregated 13F filings for Q3 2021.